Cart
sales@molnova.com
NFAT Inhibitor
CAS No. 249537-73-3
NFAT Inhibitor( —— )
Catalog No. M29714 CAS No. 249537-73-3
NFAT inhibitor is a cell-permeable compound that selectively inhibits calcineurin-mediated dephosphorylation of NFAT.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 237 | In Stock |
|
| 10MG | 429 | In Stock |
|
| 25MG | 704 | In Stock |
|
| 50MG | 981 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
Biological Information
-
Product NameNFAT Inhibitor
-
NoteResearch use only, not for human use.
-
Brief DescriptionNFAT inhibitor is a cell-permeable compound that selectively inhibits calcineurin-mediated dephosphorylation of NFAT.
-
DescriptionNFAT inhibitor is a cell-permeable compound that selectively inhibits calcineurin-mediated dephosphorylation of NFAT.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorNuclear factor of activated Tcells (NFAT)
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number249537-73-3
-
Formula Weight1685.94
-
Molecular FormulaC75H120N20O22S
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?H2O : 100 mg/mL (59.38 mM)
-
SMILES——
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
R-S-R
H-Arg-Ser-Arg-OH is a short peptide. H-Arg-Ser-Arg-OH is a motif of di-leucine and RSRR, it can be used to design larger peptides and compound.
-
BCAT-IN-2
BCAT-IN-2 is an orally active and selective inhibitor of mitochondrial branched-chain aminotransferase (BCATm), inhibits BCATm and BCATc, and is used in obesity and dyslipidemia.
-
SB290157 trifluoroac...
SB290157 trifluoroacetate is a potent and selective antagonist of C3a receptor(IC50 of 200 nM). SB 290157 is a competitive antagonist of 125I-C3a radioligand binding to rat basophilic leukemia-2H3 cells expressing the human C3aR (RBL-C3aR, IC50 of 200 nM).
